NEW YORK, Oct. 27 /PRNewswire/ -- See video from Novo Nordisk A/S at:
Novo Nordisk's operating profit increased by 24% in the first nine months of 2010. The sales growth of 17% was driven by Victoza®, NovoRapid® and Levemir®. Gross margin improved by 1.3 percentage points in Danish kroner to 80.8% in the first nine months of 2010, primarily reflecting a positive product mix development. Reported operating profit increased by 24% to DKK 14,547 million. Adjusted for the impact of currencies, operating profit in local currencies increased by around 15%. Net profit increased by 24% to DKK 10,457 million. Earnings per share (diluted) increased by 28% to DKK 17.78. Available video includes shots of Novo Nordisk's headquarters and production facilities as well as soundbites from CEO Lars Rebien Sorensen, in English and Danish.
thenewsmarket.com delivers free broadcast- and streaming-quality video and multimedia content directly to media around the world, 24/7. More than 25,000 media outlets in 190+ countries use thenewsmarket.com, including the AP, BBC, CNBC, CNN, France 24, N24, nytimes.com, RAI, TVE and ZDF.
Registered journalists can access video, audio, text, graphics and photos at http://www.thenewsmarket.com.
If you are not already registered, please take a moment to sign up - registration is quick and free: http://www.thenewsmarket.com/registration
Story Id: 20215
SOURCE thenewsmarket.com; Novo Nordisk A/S